Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia Recruiting Phase 1 Trials for Inotuzumab ozogamicin (DB05889)

IndicationStatusPhase
DBCOND0029916 (Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01925131S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute LeukemiaTreatment